BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lago SG, Tomasik J, van Rees GF, Rubey M, Gonzalez-vioque E, Ramsey JM, Haenisch F, Broek JA, Vázquez-bourgon J, Papiol S, Suarez-pinilla P, Ruland T, Auyeug B, Mikova O, Kabacs N, Arolt V, Baron-cohen S, Crespo-facorro B, Bahn S. Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum. Brain, Behavior, and Immunity 2021;91:673-82. [DOI: 10.1016/j.bbi.2020.07.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zaki JK, Lago SG, Rustogi N, Gangadin SS, Benacek J, van Rees GF, Haenisch F, Broek JA, Suarez-pinilla P, Ruland T, Auyeung B, Mikova O, Kabacs N, Arolt V, Baron-cohen S, Crespo-facorro B, Drexhage HA, de Witte LD, Kahn RS, Sommer IE, Bahn S, Tomasik J. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Transl Psychiatry 2022;12:457. [DOI: 10.1038/s41398-022-02229-w] [Reference Citation Analysis]
2 Brown JS. Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer. Neurosci Biobehav Rev 2022;141:104809. [PMID: 35970416 DOI: 10.1016/j.neubiorev.2022.104809] [Reference Citation Analysis]
3 Lago SG, Tomasik J, van Rees GF, Rustogi N, Vázquez-Bourgon J, Papiol S, Suarez-Pinilla P, Crespo-Facorro B, Bahn S. Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia. Brain Behav Immun 2022;103:37-49. [PMID: 35381347 DOI: 10.1016/j.bbi.2022.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Carnac T. Schizophrenia Hypothesis: Autonomic Nervous System Dysregulation of Fetal and Adult Immune Tolerance. Front Syst Neurosci 2022;16:844383. [DOI: 10.3389/fnsys.2022.844383] [Reference Citation Analysis]
5 Petrikis P, Polyzou A, Premeti K, Roumelioti A, Karampas A, Georgiou G, Grigoriadis D, Leondaritis G. GSK3β and mTORC1 Represent 2 Distinct Signaling Markers in Peripheral Blood Mononuclear Cells of Drug-Naive, First Episode of Psychosis Patients. Schizophr Bull 2022:sbac069. [PMID: 35757972 DOI: 10.1093/schbul/sbac069] [Reference Citation Analysis]
6 Arabska J, Wysokiński A, Brzezińska-błaszczyk E, Kozłowska E. Serum Levels and in vitro CX3CL1 (Fractalkine), CXCL8, and IL-10 Synthesis in Phytohemaglutinin-Stimulated and Non-stimulated Peripheral Blood Mononuclear Cells in Subjects With Schizophrenia. Front Psychiatry 2022;13:845136. [DOI: 10.3389/fpsyt.2022.845136] [Reference Citation Analysis]
7 Panisi C, Marini M. Dynamic and Systemic Perspective in Autism Spectrum Disorders: A Change of Gaze in Research Opens to A New Landscape of Needs and Solutions. Brain Sciences 2022;12:250. [DOI: 10.3390/brainsci12020250] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Vázquez-bourgon J, Gómez-revuelta M, Mayoral-van Son J, Labad J, Ortiz-garcía de la Foz V, Setién-suero E, Ayesa-arriola R, Tordesillas-gutiérrez D, Juncal-ruiz M, Crespo-facorro B. Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort. Eur Psychiatr 2022;65:e48. [DOI: 10.1192/j.eurpsy.2022.2308] [Reference Citation Analysis]
9 Felger JC, Capuron L. Special Issue: The intersection of inflammation and metabolism in neuropsychiatric disorders. Brain Behav Immun 2021;93:331-4. [PMID: 33378714 DOI: 10.1016/j.bbi.2020.12.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]